Filing Details

Accession Number:
0001246360-13-003372
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-27 16:42:08
Reporting Period:
2013-06-26
Filing Date:
2013-06-27
Accepted Time:
2013-06-27 16:42:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64670 Medtronic Inc MDT Electromedical & Electrotherapeutic Apparatus (3845) 410793183
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246570 Cameron D Findlay 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Srvp Gneral Counsel & Corp Sec No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-26 33,222 $36.12 106,843 No 4 M Direct
Common Stock Acquisiton 2013-06-26 31,974 $37.53 138,817 No 4 M Direct
Common Stock Acquisiton 2013-06-26 17,202 $34.88 156,019 No 4 M Direct
Common Stock Disposition 2013-06-26 75,042 $52.20 80,977 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-06-26 33,222 $0.00 33,222 $36.12
Common Stock Employee Stock Option (right to buy) Disposition 2013-06-26 31,974 $0.00 31,794 $37.53
Common Stock Employee Stock Option (right to buy) Disposition 2013-06-26 17,202 $0.00 17,202 $34.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,075 2010-11-02 2019-11-02 No 4 M Direct
31,975 2011-08-02 2020-08-02 No 4 M Direct
51,606 2012-08-01 2021-08-01 No 4 M Direct
Footnotes
  1. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
  2. This balance increased by 872.479 shares due to exempt transactions such as dividend reinvestment.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.03 to $52.33, inclusive. The reporting person undertakes to provide to Medtronic, any security holder of Medtronic, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.